GlassScriptPhysician profile
Steven A Stavrides
NPI 1578653416
$3,205.27
in general payments reported to CMS, 2019-2025
16 companies · $658 in 2025
The $658 reported for 2025 was more than what 85% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $446 · 2022: $1,009 · 2023: $425 · 2024: $667 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,500 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,499.99 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $749.99 | 2022 | |
| Avita Medical Americas, LLC | $540.16 | 2023-2024 | Recell |
| Davol INC. | $343.07 | 2024-2025 | Phasix Mesh |
| Tela Bio, INC. | $313.08 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $302.18 | 2021-2023 | Collagenase Santyl |
| Mentor Worldwide LLC | $159.43 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Solventum Corporation | $135.58 | 2024 | Prevena Restor Bellaform, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Abbvie INC. | $131.41 | 2024-2025 | |
| Axogen | $128.76 | 2025 | |
| Baxter Healthcare | $110.36 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $80.14 | 2022-2023 | |
| Convatec INC. | $72.56 | 2021-2024 | |
| Mimedx Group, INC. | $41.72 | 2024 | |
| Kerecis Limited | $37.57 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bioventus LLC | $33.25 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Stavrides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.